Company
Headquarters: Brossard, QC, Canada
CEO: Mr. Andre Larente
€25.6 Million
EUR as of Aug. 1, 2021
US$29.1 Million
Company | Market Cap (USD) |
---|---|
GE HealthCare | $34.86 B |
Veeva Systems Inc. | $29.97 B |
M3, Inc. | $11.24 B |
Change Healthcare Inc. | $9.03 B |
Signify Health, Inc. | $8.38 B |
Company | Market Cap (USD) |
---|---|
Lilly | $586.39 B |
UnitedHealth Group | $504.47 B |
Novo Nordisk | $461.52 B |
Johnson & Johnson | $387.50 B |
Merck | $296.51 B |
DIAGNOS Inc. provides software-based interpretation services primarily in Canada, the United States, Colombia, the United Arab Emirates, Bangladesh, Saudi Arabia, and Costa Rica. The company offers healthcare services through Computer Assisted Retina Analysis, a web-based software tool that assists healthcare professionals for the detection of diabetic retinopathy. It also provides various consulting services in the fields of data analysis and artificial intelligence. The company was founded in 1998 and is headquartered in Brossard, Canada.
Top 1-year algo backtest: +269.94%
$10,000 in May 2023 would now be $36,994 by following this algorithm daily at market close.
Boost your stocks returns with Disfold AI... Now!
Try Disfold AI for FREE
DIAGNOS, Inc. has the following listings and related stock indices.
Stock: FSX: 4D4A wb_incandescent
Stock: OTC: DGNOF wb_incandescent